Quick Answer
DEXCOM INC reported Stockholders Equity of $2.75 billion for fiscal year 2025.
DEXCOM INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.75B | +30.6% |
| 2024 | $2.10B | +1.6% |
| 2023 | $2.07B | -3.0% |
| 2022 | $2.13B | +4.4% |
| 2021 | $2.04B | +31.6% |
| 2020 | $1.55B | +75.8% |
| 2019 | $882.60M | +33.1% |
| 2018 | $663.30M | +58.2% |
| 2017 | $419.40M | +47.8% |
| 2016 | $283.80M | +28.3% |
| 2015 | $221.20M | +57.8% |
| 2014 | $140.20M | +66.7% |
| 2013 | $84.10M | +9.2% |
| 2012 | $77.00M | -26.3% |
| 2011 | $104.50M | +71.3% |
| 2010 | $61.00M | +431.5% |
| 2009 | -$18.40M | +5.5% |
| 2008 | -$19.47M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.73B | +37.8% | +5.9% |
| June 30, 2025 | $2.57B | +5.7% | +13.5% |
| March 31, 2025 | $2.27B | +0.9% | +7.8% |
| December 31, 2024 | $2.10B | +1.6% | +6.2% |
| September 30, 2024 | $1.98B | -12.7% | -18.7% |
| June 30, 2024 | $2.43B | +15.9% | +8.3% |
| March 31, 2024 | $2.25B | +0.6% | +8.6% |
| December 31, 2023 | $2.07B | -3.0% | -8.8% |
- DEXCOM INC showed an increase of +30.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, DEXCOM INC’s stockholders equity has grown by 14205.2% (from -$19.47 million to $2.75 billion).
- The most recent figure is from DEXCOM INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: